2. Apoptosis
  3. Caspase Apoptosis
  4. C105SR

C105SR 是一种以肽基脯氨酰反式异构酶 (PPIase) 为靶点的亲环素 D (CypD) 抑制剂，C105SR 抑制线粒体通透性转换开放 (mPTP) 的 IC 50 为 5 nM，C105SR 抑制缺氧复氧诱导的肝细胞凋亡，增加钙驻留能力 (CRC) 水平。C105SR 在缺血-再灌注损伤 (IRI) 小鼠模型中表现出肝脏保护作用。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

C105SR Chemical Structure

C105SR Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

C105SR 相关抗体

Top Publications Citing Use of Products

查看 Caspase 亚型特异性产品:

查看所有亚型
Caspase 1 Caspase 2 Caspase 3 Caspase 4 Caspase 5 Caspase 6 Caspase 7 Caspase 8 Caspase 9 Caspase 10 Caspase 12 Caspase Caspase 11 Caspase-13

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

C105SR is a cyclophilin D (CypD) inhibitor targeting to peptidyl-prolylcis-trans isomerase (PPIase). C105SR inhibits mitochondrial permeability transition opening (mPTP) with an IC 50 of 5 nM. C105SR inhibits hypoxia and reoxygenation inudced hepatocyte apoptosis and increases the level of calcium retention capacity (CRC). C105SR exhibits hepaprotective effect in ischaemia-reperfusion injury (IRI) mouse model[1].

IC50 & Target[1]

Caspase 3

 

Caspase-7

 

体外研究
(In Vitro)

C105SR (0.5/1/5/10/50/100 μM) 抑制线粒体 CypD PPIase 活性[1]。
C105SR (1μM, 4 h for hypoxia (1% O2) plus 1 h for reoxygenation (21% O2)) 可阻止 mPTP 开放[1]。
C105SR (0.5/1/5/10/50/100 μM, 4 h for hypoxia (1% O2) 减少了缺氧/复氧诱导的 AML-12 细胞死亡[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

C105SR 相关抗体:

Cell Viability Assay[1]

Cell Line: AML-12 cell
Concentration: 0.5/1/10/50/100 μM
Incubation Time: 4 h for hypoxia (1% O2) plus 2 h for reoxygenation (21% O2)
Result: Reduced LDH release and increased cell viability by approximatively 75% at 0.5μM.
体内研究
(In Vivo)

C105SR (50 mg/kg, Subcutaneous injection (s.c.), 24 h before ischaemia–reperfusion injury (IRI) surgical procedure, single dose) 在肝脏缺血再灌注损伤小鼠模型中有保护作用[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Hepatic IRI model [1]
Dosage: 50 mg/kg
Administration: Subcutaneous injection (s.c.)
Result: Protected mouse livers against the effects of ischaemia and reperfusion.
分子量

633.60

Formula

C32H33BrN4O3S
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

C105SR 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

C105SRCaspaseApoptosiscyclophilin D inhibitorhepatocyte cell lineAML-12ischaemia-reperfusion injuryhypoxia and reoxygenationInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
C105SR
目录号：
HY-157088
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z